ClinicalTrials.gg
Not yet recruitingNCT07899762Updated Nov 19, 2026

Nutrition and Swelling

A Phase 2 interventional study of Xcelerated Recovery Nutritional Supplement in Postoperative Recovery and Total Knee Arthroplasty, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of California, San Francisco · Phase 2, Interventional, and Other

How we know

Updated Nov 19, 2026Eligibility revisedPrimary outcomes revised+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

This study tests whether taking an essential amino acid (EAA) dietary supplement, Xcelerated Recovery (XR), around the time of knee replacement surgery changes the normal swelling that happens during recovery. Adults 40 years of age or older with knee osteoarthritis who are having a robotic-assisted total knee replacement at UCSF, and who screen positive for nutritional risk or reduced muscle strength, will be randomly assigned to standard care plus XR or to standard care alone. Swelling will be measured with a tape measure by a team member who does not know which group the participant is in. All participants will also use a temporary skin sensor and smartphone app (InkWell) that measures knee swelling, range of motion, and skin temperature.

Read the detailed description

This is a single-site, randomized, two-arm interventional study at UCSF evaluating the effect of perioperative supplementation with Xcelerated Recovery (XR), a commercially available EAA-based dietary supplement, on normal physiological recovery after elective primary unilateral robotic-assisted total knee arthroplasty (TKA). The study evaluates normal structure and function during recovery (limb circumference as a marker of tissue fluid balance). It is not intended to evaluate the supplement's ability to diagnose, cure, mitigate, treat, or prevent any disease.

Eighty participants will be randomized 1:1 in REDCap using permuted blocks of 4, after informed consent and confirmation of eligibility. The intervention group takes one full serving of XR dissolved in water (19.2 g EAA per serving) twice daily (38.4 g EAA per day) from 7 days before surgery through 14 days after surgery, in addition to standard care. The control group receives standard care alone.

The primary outcome is change from baseline in standardized mid-patellar and limb circumference, measured with a tape measure at baseline (about 7 days before surgery), 2 weeks, and 1 month after surgery by a trained team member who is blinded to study arm. Both groups use the InkWell remote monitoring platform (a temporary skin-applied sensor and smartphone app), which uses AI enabled software to generate exploratory measurements of knee swelling, range of motion, and skin temperature from about 7 days before surgery through postoperative day 14. Exploratory outcomes also include patient reported pain (VAS) and agreement between InkWell and tape measurements. Supplement adherence, adverse events, postoperative complications, length of stay, and 30-day readmissions are collected for descriptive and safety purposes.

02

Conditions studied

  • Postoperative Recovery
  • Total Knee Arthroplasty

Keywords

  • total knee arthroplasty
  • postoperative recovery
  • essential amino acids
  • dietary supplement
  • perioperative nutrition
  • limb circumference
  • tissue fluid balance
  • wearable sensor
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,172 studies on the registry; 370 are open to participants now.

Of its 269 completed or terminated interventional studies of FDA-regulated products, 203 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 19, 2026. See what changed

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults 40 years of age or older with knee osteoarthritis
  • Nutritional risk based on a score less than or equal to 11 on the Mini Nutritional Assessment-Short Form (MNA-SF) and/or reduced muscle strength and function based on a score greater than or equal to 4 on the SARC-F
  • Elective primary unilateral robotic-assisted TKA for osteoarthritis
  • (BMI) between 18.5 and 30 kg/m²
  • Able to provide written
  • Willing to comply with supplementation and follow-up
  • Owns a smartphone compatible with the InkWell Health app (iPhone with iOS 13 or later, or Android 5 or later), or has a caregiver with a compatible smartphone who can assist with scans

Exclusion criteria

Exclusion Criteria:

  • Revision arthroplasty
  • Arthroplasty for inflammatory arthropathy, rheumatoid arthritis, or trauma
  • Active cancer or severe metabolic disorder
  • Chronic lower-extremity edema
  • Preoperative ankle swelling
  • Lymphedema
  • Peripheral vascular disease
  • History of deep vein thrombosis (DVT)
  • Severe renal insufficiency
  • Illicit drug use
  • Known allergy to supplement ingredients
  • Inability to consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 2
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Xcelerated Recovery Nutritional Supplement

    Participants randomized to this arm will receive the Xcelerated Recovery (XR) nutritional supplement in addition to standard perioperative care. Participants will dissolve the full XR supplement dissolved in water which includes 19.2 g of essential amino acids twice daily (38.4 g/day), beginning 7 days before total knee arthroplasty and continuing through 14 days after surgery. Participants will also undergo the study's scheduled assessments and exploratory InkWell monitoring.

    Drug: Xcelerated Recovery Nutritional Supplement

  • No intervention
    Standard Care Control

    Participants randomized to this arm will receive standard perioperative care without the Xcelerated Recovery nutritional supplement. Participants will undergo the same scheduled study assessments and exploratory InkWell monitoring as the intervention group.

Interventions

  • DrugXcelerated Recovery Nutritional Supplement

    Xcelerated Recovery (XR) is a commercially available, EAA-based multi-ingredient nutritional supplement. Participants assigned to the intervention arm will dissolve the full XR supplement in water and consume it twice daily. Each serving contains 19.2 g of essential amino acids, providing 38.4 g of essential amino acids per day. Supplementation will begin 7 days before total knee arthroplasty and continue through 14 days after surgery. XR is being evaluated for its association with measures of normal physiological recovery following surgery, including tissue fluid balance assessed through changes in limb circumference.

06

What researchers measure

Primary outcomes

  1. Change in Mid-Patellar and Limb Circumference From Baseline

    Mid-patellar and limb circumference of the operative knee will be measured in centimeters using a standardized measurement technique. Change from the preoperative baseline measurement will be compared between the Xcelerated Recovery nutritional supplement and control groups as a measure of postoperative tissue fluid balance. Measured by a trained team member who is blinded to study arm.

    Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative

Other outcomes

  1. InkWell Sensor Measurement of Postoperative Tissue Fluid Changes

    The InkWell Health temporary skin sensor and associated mobile application will generate exploratory measurements related to changes in tissue fluid status. InkWell-derived measurements will be compared with standardized circumference measurements.

    Time frame: From 7 days preoperative through 14 days postoperative

  2. InkWell Sensor-Derived Knee Range of Motion

    Knee range of motion estimates generated by the InkWell monitoring platform will be collected as an exploratory outcome and compared with standardized range-of-motion measurements.

    Time frame: From 7 days preoperative through 14 days postoperative

  3. Skin Temperature Measured Using InkWell Sensor

    Skin temperature measurements generated by the InkWell monitoring platform will be collected as an exploratory measure during the perioperative monitoring period.

    Time frame: From 7 days preoperative through 14 days postoperative

  4. Xcelerated Recovery Nutritional Supplement Adherence

    Participants assigned to the Xcelerated Recovery group will report the number of prescribed supplement doses missed during the supplementation period. Adherence will be summarized based on completed versus prescribed doses.

    Time frame: From 7 days before surgery through 14 days after surgery

  5. Postoperative Complications

    Postoperative complications documented in the medical record will be collected and compared between study groups.

    Time frame: From surgery through 1 month postoperative

  6. All-Cause Hospital Readmission Within 30 Days

    The occurrence of hospital readmission following total knee arthroplasty will be determined through review of the medical record and recorded as the number and proportion of participants with at least one readmission.

    Time frame: Within 30 days after surgery

  7. Hospital Length of Stay in days following surgery until participant returns home

    Length of stay following total knee arthroplasty will be determined from the medical record and recorded as the time from hospital admission to discharge.

    Time frame: From surgical admission through hospital discharge, up to 1 month

  8. Change in Pain Score From Baseline using the Visual Analog Scale (VAS)

    Participant-reported pain will be assessed using the Visual Analog Scale (VAS) ranging from 1 (no pain) to 10 (worse pain possible). Pain scores will be collected before surgery and at postoperative follow-up visits.

    Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative

  9. Change in Operative Knee Range of Motion From Baseline

    Operative knee flexion and extension will be measured in degrees. Measurements will be obtained using the same standardized approach at each study visit to evaluate change in knee mobility during postoperative recovery.

    Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative

07

Study locations

1 site
08

References and documents

Publications

  • Li M, Shi Q, Che X, Du X, Wang D, Song Y. Study of whey protein on muscle mass and functional rehabilitation in postoperative total knee arthroplasty patients. J Back Musculoskelet Rehabil. 2024;37(5):1381-1390. doi: 10.3233/BMR-240013. PubMed 38820012 ↗
  • Dreyer HC, Owen EC, Strycker LA, Smolkowski K, Muyskens JB, Kirkpatrick TK, Christie AD, Kuehl KS, Lantz BA, Shah SN, Mohler CG, Jewett BA. Essential Amino Acid Supplementation Mitigates Muscle Atrophy After Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial. JB JS Open Access. 2018 Jun 4;3(2):e0006. doi: 10.2106/JBJS.OA.18.00006. eCollection 2018 Jun 28. PubMed 30280129 ↗
  • Dreyer HC, Strycker LA, Senesac HA, Hocker AD, Smolkowski K, Shah SN, Jewett BA. Essential amino acid supplementation in patients following total knee arthroplasty. J Clin Invest. 2013 Nov;123(11):4654-66. doi: 10.1172/JCI70160. Epub 2013 Oct 25. PubMed 24135139 ↗

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for May 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 28, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
May 1, 2027
CompletionEst.
May 1, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
Minimum age 65 Years→40 Years; 2 inclusion criteria edited, 4 added, 2 removed; 1 exclusion criterion removed
What changed in the criteria
Inclusion criteria
  • RemovedAdults over 65 years old
  • RemovedNutritional deficiency, defined as MNA-SF ≤11, and/or sarcopenia, defined as SARC-F ≥4
  • AddedAdults 40 years of age or older with knee osteoarthritis
  • AddedNutritional risk based on a score less than or equal to 11 on the Mini Nutritional Assessment-Short Form (MNA-SF) and/or reduced muscle strength and function based on a score greater than or equal to 4 on the SARC-F
  • EditedUndergoing electiveElective primary unilateral total knee arthroplasty (robotic-assisted TKA) for osteoarthritis at UCSF
  • AddedBody mass index (BMI) between 18.5 and 30 kg/m²
  • EditedWilling to comply with supplementation and follow-up requirements
  • AddedOwns a smartphone compatible with the InkWell Health app (iPhone with iOS 13 or later, or Android 5 or later), or has a caregiver with a compatible smartphone who can assist with scans
Exclusion criteria
  • RemovedBMI >35 kg/m²
Nov 19, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in Mid-Patellar and Limb Circumference From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
Nov 19, 2026
Secondary outcomes
6 added, 9 removed
What changed in the outcomes
  • RemovedChange in Operative Knee Range of Motion From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • RemovedChange in Timed Up and Go Test Time From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • RemovedChange in 10-Meter Walk Test Performance From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • RemovedChange in Operative-Leg Quadriceps Strength From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • RemovedChange in Pain Score From Baseline using the Visual Analog Scale (VAS)Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • RemovedHospital Length of Stay in days following surgery until participant returns homeTime frame: From surgical admission through hospital discharge, up to 6 weeks
  • RemovedAll-Cause Hospital Readmission Within 30 DaysTime frame: Within 30 days after surgery
  • RemovedPostoperative ComplicationsTime frame: From surgery through 1 month postoperative
  • RemovedXcelerated Recovery Nutritional Supplement AdherenceTime frame: From 7 days before surgery through 14 days after surgery
  • Addedother outcomeXcelerated Recovery Nutritional Supplement AdherenceTime frame: From 7 days before surgery through 14 days after surgery
  • Addedother outcomePostoperative ComplicationsTime frame: From surgery through 1 month postoperative
  • Addedother outcomeAll-Cause Hospital Readmission Within 30 DaysTime frame: Within 30 days after surgery
  • Addedother outcomeHospital Length of Stay in days following surgery until participant returns homeTime frame: From surgical admission through hospital discharge, up to 1 month
  • Addedother outcomeChange in Pain Score From Baseline using the Visual Analog Scale (VAS)Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
  • Addedother outcomeChange in Operative Knee Range of Motion From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
Nov 19, 2026
Registered
First appeared on the registry
Oct 28, 2026
Show all 2 updates
  1. Nov 19, 2026
    Eligibility Minimum age 65 Years→40 Years; 2 inclusion criteria edited, 4 added, 2 removed; 1 exclusion criterion removed
    What changed in the criteria
    Inclusion criteria
    • RemovedAdults over 65 years old
    • RemovedNutritional deficiency, defined as MNA-SF ≤11, and/or sarcopenia, defined as SARC-F ≥4
    • AddedAdults 40 years of age or older with knee osteoarthritis
    • AddedNutritional risk based on a score less than or equal to 11 on the Mini Nutritional Assessment-Short Form (MNA-SF) and/or reduced muscle strength and function based on a score greater than or equal to 4 on the SARC-F
    • EditedUndergoing electiveElective primary unilateral total knee arthroplasty (robotic-assisted TKA) for osteoarthritis at UCSF
    • AddedBody mass index (BMI) between 18.5 and 30 kg/m²
    • EditedWilling to comply with supplementation and follow-up requirements
    • AddedOwns a smartphone compatible with the InkWell Health app (iPhone with iOS 13 or later, or Android 5 or later), or has a caregiver with a compatible smartphone who can assist with scans
    Exclusion criteria
    • RemovedBMI >35 kg/m²
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in Mid-Patellar and Limb Circumference From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    Secondary outcomes 6 added, 9 removed
    What changed in the outcomes
    • RemovedChange in Operative Knee Range of Motion From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • RemovedChange in Timed Up and Go Test Time From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • RemovedChange in 10-Meter Walk Test Performance From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • RemovedChange in Operative-Leg Quadriceps Strength From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • RemovedChange in Pain Score From Baseline using the Visual Analog Scale (VAS)Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • RemovedHospital Length of Stay in days following surgery until participant returns homeTime frame: From surgical admission through hospital discharge, up to 6 weeks
    • RemovedAll-Cause Hospital Readmission Within 30 DaysTime frame: Within 30 days after surgery
    • RemovedPostoperative ComplicationsTime frame: From surgery through 1 month postoperative
    • RemovedXcelerated Recovery Nutritional Supplement AdherenceTime frame: From 7 days before surgery through 14 days after surgery
    • Addedother outcomeXcelerated Recovery Nutritional Supplement AdherenceTime frame: From 7 days before surgery through 14 days after surgery
    • Addedother outcomePostoperative ComplicationsTime frame: From surgery through 1 month postoperative
    • Addedother outcomeAll-Cause Hospital Readmission Within 30 DaysTime frame: Within 30 days after surgery
    • Addedother outcomeHospital Length of Stay in days following surgery until participant returns homeTime frame: From surgical admission through hospital discharge, up to 1 month
    • Addedother outcomeChange in Pain Score From Baseline using the Visual Analog Scale (VAS)Time frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    • Addedother outcomeChange in Operative Knee Range of Motion From BaselineTime frame: Baseline (preoperative), 2 weeks postoperative, and 1 month postoperative
    + 6 other changes: identifiers, verification date, description, conditions, design details and arm descriptions
  2. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07899762
Responsible party
Sponsor
First posted
Oct 28, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Malik Alhadi, BA
Contact
malik.alhadi@ucsf.edu
559-999-1036
Lorenzo Lucchetta, MD
Contact
lorenzo.lucchetta@ucsf.edu
415-416-2261
Stefano Bini, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion